Bongiovi Medical & Health Technologies’ (BMHT) medical team, led by lead investigator Dr. Thomas Haffey and CTO Joseph Butera III, presented the findings of the groundbreaking study at The American College of Cardiology/World Heart Foundation annual meeting March 4-8 in New Orleans.
PHOTO Credit Bongiovi Medical. Dr. Tom Haffey administers a non-invasive carotid artery screening test using the Aria System Auscultation platform..JPGCarotid atherosclerosis is ubiquitous and carries with it numerous pathological conditions. Every 40 seconds, someone in the US has a stroke, and every 3.5 seconds, someone dies of a stroke. High blood pressure, high cholesterol, smoking, obesity, and diabetes are leading causes of stroke, and one in three US adults has at least one of these conditions or habits. Early detection of significant carotid stenosis (SCS) and intervention are an essential component of managing the disease.
The study was conducted in late 2022 and directed by Dr. Haffey, lead investigator, and BMHT CMO Dr. Daniel Weiss.
“This bedside screening tool provides an essential component of any comprehensive stroke risk management system” said Dr Thomas Haffey, lead investigator. “As a low-cost electronic stethoscope design, this technology is well suited for underserved patient demographics and telemedicine applications and has obvious integration potential with AI methods.”